High level of mammography facility compliance in US:
This article was originally published in Clinica
Executive Summary
Compliance with the US Mammography Quality Standards Act of 1992 has reached a very high level in the third year that inspections have been required, according to the FDA. By September 18, a total of 6,432 fully certified facilities had been inspected. Of that number, 60% performed quality mammography without any violations being noted, compared with 32% in 1995, the first year of the programme. The number of serious findings has dropped to less than 1% this year compared to 2.3% in 1995.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.